Published in J Immunol on September 01, 1993
The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58
Role of chemokines in tumor growth. Cancer Lett (2007) 3.36
Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol (2002) 2.81
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest (1998) 2.42
Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev (2010) 2.32
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest (1996) 2.20
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol (1997) 2.15
Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol (2002) 2.13
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer (2011) 2.01
Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol (2002) 1.96
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol (1998) 1.75
HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res (1995) 1.74
IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res (2011) 1.73
IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene (2003) 1.72
Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol (1998) 1.66
Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol (2015) 1.65
IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol (2013) 1.65
Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev (2007) 1.63
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer (2004) 1.56
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol (2001) 1.51
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol (2000) 1.48
Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin Exp Metastasis (2003) 1.39
Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion. Exp Cell Res (2005) 1.37
HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol (1996) 1.35
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res (2009) 1.34
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br J Cancer (2009) 1.27
Dendritic cells and tumor microenvironment: a dangerous liaison. Immunol Invest (2006) 1.26
Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer (1999) 1.26
Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8. Mol Cell Biomech (2005) 1.23
The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer (1999) 1.22
The Chemokine CXCL8 in Carcinogenesis and Drug Response. ISRN Oncol (2013) 1.22
Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol (2012) 1.22
The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res (2009) 1.18
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett (2010) 1.18
Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol (1999) 1.16
Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer (1996) 1.09
Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg (2005) 1.09
Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc Natl Acad Sci U S A (2005) 1.06
Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol (1995) 1.04
Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer (1995) 1.04
Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells. J Virol (2008) 1.02
CXCL8 and its cognate receptors in melanoma progression and metastasis. Future Oncol (2010) 1.02
Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis. Int J Inflam (2011) 1.01
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene (2012) 1.00
IL-8 and cathepsin B as melanoma serum biomarkers. Int J Mol Sci (2011) 1.00
Chemokines and the microenvironment in neuroectodermal tumor-host interaction. Semin Cancer Biol (2008) 0.99
Interleukin-8 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol (2009) 0.99
Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. J Carcinog (2011) 0.99
One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment. Cell Biosci (2013) 0.97
Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int J Cancer (2010) 0.94
Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size. Otol Neurotol (2013) 0.91
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. Neoplasia (2009) 0.91
Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8. J Biol Chem (2009) 0.90
Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma. Expert Opin Ther Targets (2010) 0.89
Effects of the Tumor-Leukocyte Microenvironment on Melanoma-Neutrophil Adhesion to the Endothelium in a Shear Flow. Cell Mol Bioeng (2008) 0.89
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. Nat Commun (2014) 0.87
Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents. Bioorg Med Chem Lett (2010) 0.87
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol (1996) 0.86
Tumor cell extravasation mediated by leukocyte adhesion is shear rate dependent on IL-8 signaling. Mol Cell Biomech (2010) 0.85
Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells. Cancer Biol Ther (2015) 0.84
Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications. Int J Cancer (2010) 0.83
Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications. Br J Cancer (2000) 0.83
Mast cells in melanocytic tumours. Arch Dermatol Res (1995) 0.82
Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice. Cell Immunol (2011) 0.81
Ectopic G-CSF expression in human melanoma lines marks a trans-dominant pathway of tumor progression. Am J Pathol (1997) 0.81
Exploiting tumor cell senescence in anticancer therapy. BMB Rep (2014) 0.80
The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch Dermatol Res (1996) 0.79
Stem cell factor affects tumour progression markers in metastatic melanoma cells. Clin Exp Metastasis (2006) 0.79
Normal and SV40 transfected human peritoneal mesothelial cells produce IL-6 and IL-8: implication for gynaecological disease. Clin Exp Immunol (2002) 0.78
Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation (2010) 0.77
Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy. J Endocrinol Invest (2015) 0.77
Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density. Am J Pathol (1996) 0.77
A synthetic peptide inhibitor for alpha-chemokines inhibits the growth of melanoma cell lines. J Clin Invest (1997) 0.76
The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils. Front Immunol (2016) 0.75
Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Silencing of CXCR2 and CXCR7 protects against esophageal cancer. Am J Transl Res (2016) 0.75
Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis. Oncol Lett (2017) 0.75
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition. J Exp Med (2017) 0.75
Evidence of lateral transmission of aggressive features between different types of breast cancer cells. Int J Oncol (2017) 0.75
Molecular and phenotypic biomarkers of aging. F1000Res (2017) 0.75
Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81
Antibodies to left-handed Z-DNA bind to interband regions of Drosophila polytene chromosomes. Nature (1981) 3.69
Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (1986) 3.25
Antibodies specific for left-handed Z-DNA. Proc Natl Acad Sci U S A (1981) 3.05
Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood (1990) 2.42
Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy (2007) 2.35
Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell (1998) 2.24
A method of sampling human dental plaque for certain "caries-inducing" streptococci. Arch Oral Biol (1968) 2.17
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis (1992) 2.11
EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05
Isolation of Drosophila proteins that bind selectively to left-handed Z-DNA. Proc Natl Acad Sci U S A (1982) 2.01
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Monoclonal antibodies recognize different parts of Z-DNA. J Biol Chem (1982) 1.74
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73
Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res (1991) 1.63
Bromination stabilizes poly(dG-dC) in the Z-DNA form under low-salt conditions. Biochemistry (1984) 1.63
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol (2009) 1.60
Insulin allergy: clinical manifestations and management strategies. Allergy (2008) 1.56
Demodicidosis revisited. Acta Derm Venereol (2002) 1.54
Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol (1995) 1.54
Mast cells. Int J Dermatol (1995) 1.52
Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol (1995) 1.50
IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol (1990) 1.50
Allergen extract-induced interleukin-10 in human memory B cells inhibits immunoglobulin E production. Clin Exp Allergy (2009) 1.47
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis (2005) 1.47
Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy (2004) 1.45
Human mast cells produce IL-8. J Immunol (1993) 1.44
Thymic stromal lymphopoietin induction by skin irritation is independent of tumour necrosis factor-α, but supported by interleukin-1. Br J Dermatol (2015) 1.42
Drug-eluting coronary stents: hypersensitivity reactions to paclitaxel. A case report. Dermatology (2008) 1.39
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39
Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol (1994) 1.39
Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res (2000) 1.37
Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy (2007) 1.35
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol (2000) 1.33
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
7-Methylguanine in poly(dG-dC).poly(dG-dC) facilitates z-DNA formation. Proc Natl Acad Sci U S A (1981) 1.31
Prevalence of adverse reactions to food in Germany - a population study. Allergy (2004) 1.31
Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30
Life 20 years after unsuccessful infertility treatment. Hum Reprod (2006) 1.29
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol (2007) 1.28
GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy (2010) 1.28
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
The epidemiology of anaphylaxis in Europe: a systematic review. Allergy (2013) 1.26
Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest (1992) 1.25
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22
A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol (1994) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol (1981) 1.15
Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol (1984) 1.13
Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol (2010) 1.12
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. J Pathol (2008) 1.12
Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol (1991) 1.10
Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun (1998) 1.10
The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol (1995) 1.09
Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy (2009) 1.09
Z-DNA-specific antibodies in human systemic lupus erythematosus. J Clin Invest (1983) 1.09
Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol (1994) 1.08
Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol (1993) 1.08
Bacteria recovered from teeth with apical periodontitis after antimicrobial endodontic treatment. Int Endod J (2003) 1.07
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol (1990) 1.05
Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity. Cancer Res (1986) 1.05
Does psychological stress affect the outcome of in vitro fertilization? Hum Reprod (2005) 1.02
Mast cells as initiators of immunity and host defense. Exp Dermatol (2001) 1.02
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol (1999) 1.01
Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol (1995) 1.01
Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions. Allergy (2012) 1.00
Management of anaphylaxis: a systematic review. Allergy (2013) 0.99
Nodular morphea. Dermatology (2008) 0.99
First IVF treatment--short-term impact on psychological well-being and the marital relationship. Hum Reprod (2006) 0.99
The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol (1998) 0.99
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res (1994) 0.98
In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. Prostaglandins (1985) 0.98
Analysis of Z-DNA in fixed polytene chromosomes with monoclonal antibodies that show base sequence-dependent selectivity in reactions with supercoiled plasmids and polynucleotides. J Biol Chem (1986) 0.98
Bronchogenic cyst. A rare differential diagnosis of retroperitoneal tumors. Urol Int (2000) 0.98
Prevalence of physical and sexual abuse before and during pregnancy among Swedish couples. Acta Obstet Gynecol Scand (1999) 0.98
Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest (1997) 0.98
Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol (2000) 0.97
Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol (1993) 0.97
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response. Allergy (2010) 0.96
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol (1998) 0.96
Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet (1999) 0.96
Hair growth induction by substance P. Lab Invest (1994) 0.96
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol (1984) 0.95
Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro. Prostaglandins (1986) 0.95
Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis. Clin Exp Immunol (2004) 0.94
Schnitzler's syndrome: successful treatment of two patients using thalidomide. Br J Dermatol (2003) 0.94
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol (1994) 0.94
Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: effect of cyclosporin A. Cytokine (1991) 0.94
Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr (2011) 0.93